Introduction to Diurnal Preference and Mood Heterogeneity

Depressive disorders exhibit profound clinical and neurobiological heterogeneity, complicating diagnosis and treatment selection. Consequently, identifying specific depressive phenotypes driven by distinct biological and environmental pathways remains a crucial objective in psychiatric research. Emerging evidence highlights diurnal preference—the endogenous circadian tendency toward morningness or eveningness—as a major candidate phenotype linked to affective regulation. Polygenic architecture governs baseline circadian variations, while environmental stressors encountered during critical developmental periods, such as childhood adversities, dynamically alter genetic vulnerability. Evaluating how morning chronotype depression risk interacts with early traumatic exposure provides vital insight into sex-specific psychiatric susceptibility. Large-scale genome-wide association studies have identified multiple single nucleotide polymorphisms regulating diurnal preference. Although chronotype polygenic risk scores alone do not directly correlate with depressive symptom severity in general populations, evaluating genetic risk alongside childhood trauma reveals crucial gene-environment interactions. These findings emphasize that depression arises from complex interactions between polygenic traits, early adversity, and biological sex.

GWAS Findings on Morning Chronotype Depression Risk

To elucidate the genetic underpinnings of circadian preference, researchers conducted genome-wide association studies using a discovery sample of 273,033 participants. Polygenic risk scores were subsequently calculated in a target cohort of 25,476 individuals separately for morning and evening chronotypes. Genomic mapping identified 39 significant lead single nucleotide polymorphisms and 44 genes associated with morningness, alongside 69 lead variants and 76 genes associated with eveningness. Heritability estimates were comparable, recorded at 12.1% for morning chronotype and 11.8% for evening chronotype. Notably, statistical analyses demonstrated no significant direct main effect of chronotype polygenic risk scores on overall depressive symptom scores across the general target population. This finding indicates that genetic liability for diurnal preference does not independently drive depressive outcomes. Instead, chronotype genetic risk acts as a biological latent vulnerability that requires environmental triggers or sex-specific physiological factors to manifest as clinical depressive symptoms.

Gene-Environment Interactions and Early Life Adversity

While genetic liability for diurnal preference lacks a direct main effect on depressive symptoms, integrating environmental trauma unveils critical disease mechanisms. Early childhood adversity, including physical, emotional, or sexual abuse, alters neurodevelopment and stress response systems permanently. When analyzing polygenic risk scores in interaction with childhood trauma, researchers observed a significant sex-dependent effect. In women exposed to early adversities, higher genetic liability for morningness significantly predicted increased depressive symptom scores. This unexpected interaction challenges traditional beliefs that eveningness is uniquely tied to psychiatric risk. Instead, morningness genetic liability appears to confer heightened biological sensitivity to early environmental trauma specifically in female individuals. The underlying pathomechanism may involve altered circadian gene expression within limbic networks, disrupted cortisol rhythms, and elevated stress sensitivity following developmental trauma. Evaluating childhood trauma alongside genetic data thus clarifies how early stress translates into adult affective dysfunction.

Sex-Specific Pathomechanisms in Major Depressive Disorder

Biological sex fundamentally influences depression pathophysiology, affecting neuroendocrine regulation, immune responses, and neural plasticity. The sex-specific interaction between morning chronotype genetic liability and childhood trauma highlights distinct biological pathways in female mood disorders. Oestrogen and progesterone modulate core circadian clock genes, altering circadian amplitude and vulnerability to stress. Consequently, women possessing high morningness genetic risk may experience heightened circadian dysregulation when exposed to early life trauma. In contrast, male participants did not demonstrate this gene-environment interaction, pointing to distinct physiological mechanisms governing stress vulnerability in men. Epigenetic modifications triggered by early adversity may also alter locus-specific chromatin structure in females, selectively impacting circadian gene expression. These findings stress the importance of stratifying psychiatric genetic analyses by biological sex. Disaggregating clinical data prevents masking critical sex-dependent vulnerabilities, ultimately guiding the development of sex-tailored diagnostic and therapeutic strategies.

Clinical Implications for Biomarker Discovery and Prevention

Integrating polygenic risk scores with detailed trauma assessments offers significant potential for preventive psychiatry and clinical decision-making. Conventional diagnostic criteria rely heavily on subjective symptom clustering, often missing underlying aetiological mechanisms. Combining chronotype genetic profiles with standardized childhood trauma screeners enables clinicians to identify high-risk female patients before severe depressive symptoms emerge. Early identification allows targeted psychosocial and chronotherapeutic interventions, such as sleep hygiene optimization and light therapy, to stabilize circadian alignment. Furthermore, clinicians should routinely evaluate early life trauma during psychiatric assessments, as developmental stress profoundly alters the clinical impact of genetic liability. Transitioning toward multi-dimensional risk stratification bridges genomic research and clinical practice. This personalized approach enhances diagnostic accuracy, improves preventive care, and enables clinicians to deliver targeted, patient-specific interventions for vulnerable populations.

Future Directions in Precision Psychiatry and Research

Discovering sex-dependent interactions between morning chronotype genetics and childhood trauma represents a vital step toward precision psychiatry. However, expanding research across diverse ancestral populations is essential, as current genomic cohorts are predominantly European. Diverse global studies will ensure the broad clinical applicability of polygenic risk scores. Furthermore, longitudinal research tracking neuroendocrine markers, circadian rhythms, and mood symptoms from childhood into adulthood will clarify the temporal dynamics of these gene-environment interactions. Studies should also investigate whether specific trauma subtypes, such as emotional neglect versus physical abuse, interact differently with chronotype genetics. Incorporating multi-omic analyses—combining genomics, epigenomics, and transcriptomics—will further elucidate how morningness variants alter regional brain function. Ultimately, refining these polygenic interaction models will facilitate the discovery of novel circadian-targeted therapeutics and advance personalized psychiatric care.

How does genetic predisposition to morning chronotype affect depression risk?

Genetic liability for morning chronotype does not directly cause depression as a simple main effect. However, in women who experienced childhood trauma, higher polygenic risk scores for morningness interact with early environmental stress to significantly increase depressive symptom severity, demonstrating a sex-specific gene-environment interaction.

Why are sex differences significant in gene-environment interaction studies?

Sex differences modulate biological responses to stress through distinct neuroendocrine, epigenetic, and immune mechanisms. Fluctuations in sex hormones interact with core circadian clock genes, altering biological sensitivity to early trauma and explaining why morningness genetic risk specifically predicts depressive symptoms in females rather than males.

What clinical tools can help translate polygenic risk scores into practice?

Translating polygenic risk scores into clinical practice requires integrating genetic profiling with comprehensive clinical evaluations, including standardized childhood trauma screeners and chronotype questionnaires. Combining genomic data with developmental history enables clinicians to stratify psychiatric risk, personalize chronotherapeutic interventions, and implement targeted early prevention strategies.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Healthcare professionals should rely on their professional judgment and local clinical guidelines when evaluating and treating patients. Refer to the latest local and national guidelines for clinical practice.

References

Gyorik D et al. Genetic liability for morning chronotype interacts with childhood trauma to predict depressive symptoms in women. Dialogues Clin Neurosci. 2026 Dec. doi: 10.1080/19585969.2026.2702037. PMID: 42472452.

Purves KL et al. Polygenic risk scores and gene-environment interactions in psychiatric genetics: clinical utility and challenges. World Psychiatry. 2020;19(3):321-332.

Lane JM et al. Biological and clinical insights from genetics of diurnal preference and sleep patterns. Nat Commun. 2019;10(1):1598.